[1]
“Different concentrations of nivolumab reduce PD-1 expression but not tumour growth in an EMT6 mouse model”, Biomed. Res. Ther., vol. 11, no. 2, pp. 6191–6197, Feb. 2024, doi: 10.15419/bmrat.v11i2.864.